Is botulinum neurotoxin serotype D poorly effective in humans : an in vivo electrophysiological study?
Botulinum toxin type D is very potent in mice and almost ineffective in humans in vivo.
Impaired medial SMC recovery in murine aortic allografts at 2 weeks occurs in the absence of adaptive immunity. Enhanced medial SMC recovery and reduced neointimal lesion formation in NOX2(-/-) and rIPC recipients of 60-minute CI grafts suggest a causal role for NØs in impaired medial SMC repopulation and the development of AV.